Next Article in Journal
Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS
Previous Article in Journal
Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma
 
 
Review

Article Versions Notes

Cancers 2021, 13(4), 670; https://doi.org/10.3390/cancers13040670
Action Date Notes Link
article html file updated 25 December 2025 03:38 CET Update https://www.mdpi.com/2072-6694/13/4/670/html
article html file updated 1 September 2025 21:02 CEST Update -
article html file updated 24 July 2022 19:05 CEST Update -
article html file updated 7 February 2021 12:46 CET Original file -
article pdf uploaded. 7 February 2021 12:44 CET Version of Record https://www.mdpi.com/2072-6694/13/4/670/pdf
article xml uploaded. 7 February 2021 12:44 CET Update https://www.mdpi.com/2072-6694/13/4/670/xml
article xml file uploaded 7 February 2021 12:44 CET Original file -
Back to TopTop